Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Current Design of New Psychoactive Substances

Author(s): Francesco Paolo Busardò and Simona Zaami

Volume 28, Issue 15, 2022

Published on: 24 June, 2022

Page: [1211 - 1212] Pages: 2

DOI: 10.2174/138161282815220624141644

Next »
[1]
European Drug Report 2022: Trends and Developments at . https://www.emcdda.europa.eu/publications/edr/trends-developments/2022_en
[2]
Simão AY, Antunes M, Cabral E, et al. An update on the implications of new psychoactive substances in public health. Int J Environ Res Public Health 2022; 19(8): 4869.
[3]
Busardo FP, Pichini S, Pellegrini M, et al. Correlation between blood and oral fluid psychoactive drug concentrations and cognitive impairment in driving under the influence of drugs. Curr Neuropharmacol 2018; 16(1): 84-96.
[4]
Zaami S, Busardò FP, Pichini S, Pacifici R, Marinelli E. The value of toxicological and forensic analyses in the global challenge to health risks caused by new psychoactive substances. Eur Rev Med Pharmacol Sci 2019; 23(14): 6008-10.
[5]
Zaami S, Graziano S, Tittarelli R, Beck R, Marinelli E. BDZs, Designer BDZs and Z-drugs: Pharmacology and misuse insights. Curr Pharm Des 2022; 28(15): 1221-9.
[6]
Gish A, Dumestre-Toulet V, Richeval C, et al. Trends in the pharmaceutical design of new psychoactive substances detected in oral fluid of drivers around a music festival in south-west france: Comparison 2019/2017. Curr Pharm Des 2022; 28(15): 1245-9.
[7]
EU acts on rising concern over synthetic drugs GHB and ketamine at . https://www.emcdda.europa.eu/news/2001/eu-acts-rising-concern-over-synthetic-drugs-ghb-and-ketamine_en
[8]
Varì MR, Ricci G, Cavallo M, Pichini S, Sirignano A, Graziano S. Ketamine: From prescription anaesthetic to new psychoactive substance. Curr Pharm Des 2022; 28(15): 1213-20.
[9]
Sarah MR, Wille SMR, Desharnais B, Pichini S, et al. Liquid chromatography high-resolution mass spectrometry in forensic toxicology: What are the specifics of method development, validation and quality assurance for comprehensive screening approaches? Curr Pharm Des 2022; 28(15): 1230-44.
[10]
Peters FT, Wissenbach DK, Busardo FP, Marchei E, Pichini S. Method development in forensic toxicology. Curr Pharm Des 2017; 23(36): 5455-67.
[11]
Wille SMR, Coucke W, De Baere T, Peters FT. Update of standard practices for new method validation in forensic toxicology. Curr Pharm Des 2017; 23(36): 5442-54.

Rights & Permissions Print Cite
Article Metrics
17
2
© 2024 Bentham Science Publishers | Privacy Policy